1. Home
  2. WORX vs OGEN Comparison

WORX vs OGEN Comparison

Compare WORX & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WORX
  • OGEN
  • Stock Information
  • Founded
  • WORX N/A
  • OGEN 1996
  • Country
  • WORX United States
  • OGEN United States
  • Employees
  • WORX N/A
  • OGEN N/A
  • Industry
  • WORX Services-Misc. Amusement & Recreation
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WORX Consumer Discretionary
  • OGEN Health Care
  • Exchange
  • WORX Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • WORX 1.1M
  • OGEN 1.2M
  • IPO Year
  • WORX N/A
  • OGEN N/A
  • Fundamental
  • Price
  • WORX $0.32
  • OGEN $1.03
  • Analyst Decision
  • WORX
  • OGEN
  • Analyst Count
  • WORX 0
  • OGEN 0
  • Target Price
  • WORX N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • WORX 8.8M
  • OGEN 112.5K
  • Earning Date
  • WORX 08-14-2025
  • OGEN 08-08-2025
  • Dividend Yield
  • WORX N/A
  • OGEN N/A
  • EPS Growth
  • WORX N/A
  • OGEN N/A
  • EPS
  • WORX N/A
  • OGEN N/A
  • Revenue
  • WORX $2,838,404.00
  • OGEN N/A
  • Revenue This Year
  • WORX N/A
  • OGEN N/A
  • Revenue Next Year
  • WORX N/A
  • OGEN N/A
  • P/E Ratio
  • WORX N/A
  • OGEN N/A
  • Revenue Growth
  • WORX N/A
  • OGEN N/A
  • 52 Week Low
  • WORX $0.26
  • OGEN $1.01
  • 52 Week High
  • WORX $3.31
  • OGEN $36.90
  • Technical
  • Relative Strength Index (RSI)
  • WORX 49.20
  • OGEN 32.50
  • Support Level
  • WORX $0.31
  • OGEN $1.01
  • Resistance Level
  • WORX $0.36
  • OGEN $1.13
  • Average True Range (ATR)
  • WORX 0.06
  • OGEN 0.05
  • MACD
  • WORX 0.01
  • OGEN 0.04
  • Stochastic Oscillator
  • WORX 19.35
  • OGEN 26.32

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: